Richard Reed Love
Research Subjects
Richard Reed Love has a total of 140 co-authors. Here are the top co-authors by number of shared publications:
- Deepak Sundar Shrestha
Affiliation Peoples Dental College and Hospital, Kathmandu, Nepal
4 shared publications - Erinn M. Hade
Department of Population Health, New York University Grossman School of Medicine , New York, NY 10016
4 shared publications - Sheikh Iqbal Ahamed
Department of Computer Science, Marquette University, Milwaukee, WI 53233, USA
4 shared publications - Gregory S. Young
Center for Biostatistics, The Ohio State University, Columbus, Ohio, USA
3 shared publications - Hasanul Aziz
Department of Computer Science, Marquette University, Milwaukee, WI, United States
3 shared publications - Nguyen Van Dinh
Department of Breast Surgery, National Cancer Hospital, Hanoi, Vietnam
3 shared publications
Latest Publications
- Open Access
- 12 June 2025
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 5 (6) , e0004270
Illness and treatment beliefs in Kathmandu valley Nepalis under hypertensive care
The prevalence of actionable (i.e., stage 2 = BP > 140/90) hypertension among Nepalis approaches one-third in the adult population. Long-term drug treatment adherence is low. Western-developed assessment tools present an incomplete picture of the regional Nepali beliefs that guide patient treatment adherence, and the present study seeks to substantiate qualitative findings that suggest a reorientation of patient education content for more effective patient-oriented, culturally consonant care. We conducted a cross-sectional structured interview of 500 men and women under treatment for hypertension in three urban Kathmandu hospital clinics. Interview items were developed from a qualitative survey and investigated patient beliefs about hypertension causes, symptoms, and consequences; treatment costs and sequelae; and general health maintenance. Patients reported experiencing multiple and wide-ranging symptoms that affected how they felt physically and emotionally as well as how they behaved; these were expected to respond to treatment. They were distressed by their condition and were concerned about short- and long-term treatment effects, specifically that long-term treatment may impair the body’s natural ability to maintain a healthy blood pressure. While hypertension was described as life-long, there was a range of beliefs on whether successful blood pressure control would, or should, allow a switch to natural remedies, lifestyle management, or no treatment at all. Kathmandu Valley hypertension beliefs suggest adaptation of Western-developed patient communications to address Nepali patient experience and concerns. While Western communications address the “silent” nature of the disease, our Kathmandu population experienced multiple and varied symptoms that guided their behavior. Patient also expressed concerns about medication habituation and dependence reflecting Nepali health models.
- 12 June 2025
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 5 (6) , e0004270
Open AccessIllness and treatment beliefs in Kathmandu valley Nepalis under hypertensive care
The prevalence of actionable (i.e., stage 2 = BP > 140/90) hypertension among Nepalis approaches one-third in the adult population. Long-term drug treatment adherence is low. Western-developed assessment tools present an incomplete picture of the regional Nepali beliefs that guide patient treatment adherence, and the present study seeks to substantiate qualitative findings that suggest a reorientation of patient education content for more effective patient-oriented, culturally consonant care. We conducted a cross-sectional structured interview of 500 men and women under treatment for hypertension in three urban Kathmandu hospital clinics. Interview items were developed from a qualitative survey and investigated patient beliefs about hypertension causes, symptoms, and consequences; treatment costs and sequelae; and general health maintenance. Patients reported experiencing multiple and wide-ranging symptoms that affected how they felt physically and emotionally as well as how they behaved; these were expected to respond to treatment. They were distressed by their condition and were concerned about short- and long-term treatment effects, specifically that long-term treatment may impair the body’s natural ability to maintain a healthy blood pressure. While hypertension was described as life-long, there was a range of beliefs on whether successful blood pressure control would, or should, allow a switch to natural remedies, lifestyle management, or no treatment at all. Kathmandu Valley hypertension beliefs suggest adaptation of Western-developed patient communications to address Nepali patient experience and concerns. While Western communications address the “silent” nature of the disease, our Kathmandu population experienced multiple and varied symptoms that guided their behavior. Patient also expressed concerns about medication habituation and dependence reflecting Nepali health models.
- Open Access
- 31 January 2025
- Published by Archives of Breast Cancer in Archives of Breast Cancer
- Vol. 12 (1) , 1-4
Bridging the Breast Care Divide: Point-of-Care Ultrasound for all Women with Breast Problems
- 31 January 2025
- Published by Archives of Breast Cancer in Archives of Breast Cancer
- Vol. 12 (1) , 1-4
Open AccessBridging the Breast Care Divide: Point-of-Care Ultrasound for all Women with Breast Problems
- Open Access
- 11 March 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (3) , e0299141
Symptoms 6 months following SARS-CoV-2 infection in Nepali women
In Nepal, over 1 million individuals have tested positive for SARS-CoV-2. We sought to describe the frequency of nonrecovery from this infection at 6 months and associated symptoms. We conducted a retrospective cohort study of 6142 women who had positive and negative PCR tests for this infection 6 months previously at 3 institutions in Kathmandu. In telephone interviews women provided information on 22 symptoms and their intensities, health status and history, and functional status. Of 3732 women who had tested PCR positive, 630 (16.9%) reported that they were unrecovered. These 630 unrecovered women were distinguished statistically from the 3102 recovered women by more frequent histories of allergies, rheumatoid disease, BCG immunization, Covid vaccination, strep throat and recent URIs, and both weight gain and weight losses of more than 5 kg in the 6 months following testing, and stressful events in the preceding year. Fatigue, pain, difficulty remembering, shortness of breath, heat and cold intolerance and unrefreshing sleep were reported in 41.9% to 10.5% of these 630 unrecovered women. Six months after confirmed SARS-CoV-2 infection 16.9% of Nepali women have long-COVID manifested as an immune, metabolic, and hormonal systems disruptive and dysfunction syndrome
- 11 March 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (3) , e0299141
Open AccessSymptoms 6 months following SARS-CoV-2 infection in Nepali women
In Nepal, over 1 million individuals have tested positive for SARS-CoV-2. We sought to describe the frequency of nonrecovery from this infection at 6 months and associated symptoms. We conducted a retrospective cohort study of 6142 women who had positive and negative PCR tests for this infection 6 months previously at 3 institutions in Kathmandu. In telephone interviews women provided information on 22 symptoms and their intensities, health status and history, and functional status. Of 3732 women who had tested PCR positive, 630 (16.9%) reported that they were unrecovered. These 630 unrecovered women were distinguished statistically from the 3102 recovered women by more frequent histories of allergies, rheumatoid disease, BCG immunization, Covid vaccination, strep throat and recent URIs, and both weight gain and weight losses of more than 5 kg in the 6 months following testing, and stressful events in the preceding year. Fatigue, pain, difficulty remembering, shortness of breath, heat and cold intolerance and unrefreshing sleep were reported in 41.9% to 10.5% of these 630 unrecovered women. Six months after confirmed SARS-CoV-2 infection 16.9% of Nepali women have long-COVID manifested as an immune, metabolic, and hormonal systems disruptive and dysfunction syndrome
- Open Access
- 15 January 2022
- Published by Journal of Nepal Medical Association (JNMA) in Journal of Nepal Medical Association
- Vol. 60 (245) , 101-105
Cancer Prevention Strategies for Nepal
In Nepal, the commonest major malignancies and causes of cancer death are lung, cervix, stomach, breast, head and neck (lip, mouth, pharynx, larynx), gallbladder, ovary and liver. There are seven cancer-causative exposures which should be the focus of attention such as; tobacco smoking in 29% of men, and 6% of women, solid fuel burning in 69% of homes (multiple cancers), betel-nut chewing in 40 % of men and 3% of women (head and neck cancers), alcohol abuse (liver and other cancers), Human Papilloma Virus (cervical cancer), Helicobacter pylori (stomach cancer) and Hepatitis B virus (liver cancer). To better address these reducible exposures, we suggest greater targeted strategies in three areas: Public health messaging for tobacco, solid-fuel burning, betel-nut, and alcohol; national policies for Hepatitis B virus vaccination; and analytic epidemiological and interventional research for Human Papilloma Virus and helicobacter.
- 15 January 2022
- Published by Journal of Nepal Medical Association (JNMA) in Journal of Nepal Medical Association
- Vol. 60 (245) , 101-105
Open AccessCancer Prevention Strategies for Nepal
In Nepal, the commonest major malignancies and causes of cancer death are lung, cervix, stomach, breast, head and neck (lip, mouth, pharynx, larynx), gallbladder, ovary and liver. There are seven cancer-causative exposures which should be the focus of attention such as; tobacco smoking in 29% of men, and 6% of women, solid fuel burning in 69% of homes (multiple cancers), betel-nut chewing in 40 % of men and 3% of women (head and neck cancers), alcohol abuse (liver and other cancers), Human Papilloma Virus (cervical cancer), Helicobacter pylori (stomach cancer) and Hepatitis B virus (liver cancer). To better address these reducible exposures, we suggest greater targeted strategies in three areas: Public health messaging for tobacco, solid-fuel burning, betel-nut, and alcohol; national policies for Hepatitis B virus vaccination; and analytic epidemiological and interventional research for Human Papilloma Virus and helicobacter.
- Open Access
- 8 April 2021
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 9 (4) , e16806
Noninvasive Hemoglobin Level Prediction in a Mobile Phone Environment: State of the Art Review and Recommendations
Background: There is worldwide demand for an affordable hemoglobin measurement solution, which is a particularly urgent need in developing countries. The smartphone, which is the most penetrated device in both rich and resource-constrained areas, would be a suitable choice to build this solution. Consideration of a smartphone-based hemoglobin measurement tool is compelling because of the possibilities for an affordable, portable, and reliable point-of-care tool by leveraging the camera capacity, computing power, and lighting sources of the smartphone. However, several smartphone-based hemoglobin measurement techniques have encountered significant challenges with respect to data collection methods, sensor selection, signal analysis processes, and machine-learning algorithms. Therefore, a comprehensive analysis of invasive, minimally invasive, and noninvasive methods is required to recommend a hemoglobin measurement process using a smartphone device. Objective: In this study, we analyzed existing invasive, minimally invasive, and noninvasive approaches for blood hemoglobin level measurement with the goal of recommending data collection techniques, signal extraction processes, feature calculation strategies, theoretical foundation, and machine-learning algorithms for developing a noninvasive hemoglobin level estimation point-of-care tool using a smartphone. Methods: We explored research papers related to invasive, minimally invasive, and noninvasive hemoglobin level measurement processes. We investigated the challenges and opportunities of each technique. We compared the variation in data collection sites, biosignal processing techniques, theoretical foundations, photoplethysmogram (PPG) signal and features extraction process, machine-learning algorithms, and prediction models to calculate hemoglobin levels. This analysis was then used to recommend realistic approaches to build a smartphone-based point-of-care tool for hemoglobin measurement in a noninvasive manner. Results: The fingertip area is one of the best data collection sites from the body, followed by the lower eye conjunctival area. Near-infrared (NIR) light-emitting diode (LED) light with wavelengths of 850 nm, 940 nm, and 1070 nm were identified as potential light sources to receive a hemoglobin response from living tissue. PPG signals from fingertip videos, captured under various light sources, can provide critical physiological clues. The features of PPG signals captured under 1070 nm and 850 nm NIR LED are considered to be the best signal combinations following a dual-wavelength theoretical foundation. For error metrics presentation, we recommend the mean absolute percentage error, mean squared error, correlation coefficient, and Bland-Altman plot. Conclusions: We addressed the challenges of developing an affordable, portable, and reliable point-of-care tool for hemoglobin measurement using a smartphone. Leveraging the smartphone’s camera capacity, computing power, and lighting sources, we define specific recommendations for practical point-of-care solution development. We further provide recommendations to resolve several long-standing research questions, including how to capture a signal using a smartphone camera, select the best body site for signal collection, and overcome noise issues in the smartphone-captured signal. We also describe the process of extracting a signal’s features after capturing the signal based on fundamental theory. The list of machine-learning algorithms provided will be useful for processing PPG features. These recommendations should be valuable for future investigators seeking to build a reliable and affordable hemoglobin prediction model using a smartphone.
- 8 April 2021
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 9 (4) , e16806
Open AccessNoninvasive Hemoglobin Level Prediction in a Mobile Phone Environment: State of the Art Review and Recommendations
Background: There is worldwide demand for an affordable hemoglobin measurement solution, which is a particularly urgent need in developing countries. The smartphone, which is the most penetrated device in both rich and resource-constrained areas, would be a suitable choice to build this solution. Consideration of a smartphone-based hemoglobin measurement tool is compelling because of the possibilities for an affordable, portable, and reliable point-of-care tool by leveraging the camera capacity, computing power, and lighting sources of the smartphone. However, several smartphone-based hemoglobin measurement techniques have encountered significant challenges with respect to data collection methods, sensor selection, signal analysis processes, and machine-learning algorithms. Therefore, a comprehensive analysis of invasive, minimally invasive, and noninvasive methods is required to recommend a hemoglobin measurement process using a smartphone device. Objective: In this study, we analyzed existing invasive, minimally invasive, and noninvasive approaches for blood hemoglobin level measurement with the goal of recommending data collection techniques, signal extraction processes, feature calculation strategies, theoretical foundation, and machine-learning algorithms for developing a noninvasive hemoglobin level estimation point-of-care tool using a smartphone. Methods: We explored research papers related to invasive, minimally invasive, and noninvasive hemoglobin level measurement processes. We investigated the challenges and opportunities of each technique. We compared the variation in data collection sites, biosignal processing techniques, theoretical foundations, photoplethysmogram (PPG) signal and features extraction process, machine-learning algorithms, and prediction models to calculate hemoglobin levels. This analysis was then used to recommend realistic approaches to build a smartphone-based point-of-care tool for hemoglobin measurement in a noninvasive manner. Results: The fingertip area is one of the best data collection sites from the body, followed by the lower eye conjunctival area. Near-infrared (NIR) light-emitting diode (LED) light with wavelengths of 850 nm, 940 nm, and 1070 nm were identified as potential light sources to receive a hemoglobin response from living tissue. PPG signals from fingertip videos, captured under various light sources, can provide critical physiological clues. The features of PPG signals captured under 1070 nm and 850 nm NIR LED are considered to be the best signal combinations following a dual-wavelength theoretical foundation. For error metrics presentation, we recommend the mean absolute percentage error, mean squared error, correlation coefficient, and Bland-Altman plot. Conclusions: We addressed the challenges of developing an affordable, portable, and reliable point-of-care tool for hemoglobin measurement using a smartphone. Leveraging the smartphone’s camera capacity, computing power, and lighting sources, we define specific recommendations for practical point-of-care solution development. We further provide recommendations to resolve several long-standing research questions, including how to capture a signal using a smartphone camera, select the best body site for signal collection, and overcome noise issues in the smartphone-captured signal. We also describe the process of extracting a signal’s features after capturing the signal based on fundamental theory. The list of machine-learning algorithms provided will be useful for processing PPG features. These recommendations should be valuable for future investigators seeking to build a reliable and affordable hemoglobin prediction model using a smartphone.
- Open Access
- 24 March 2021
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Biomedical and Health Informatics
- Vol. 25 (5) , 1385-1396
Automated Cardiac Pulse Cycle Analysis From Photoplethysmogram (PPG) Signals Generated From Fingertip Videos Captured Using a Smartphone to Measure Blood Hemoglobin Levels
Two billion people are affected by hemoglobin (Hgb) related diseases. Usual clinical assessments of hemoglobin are conducted by analyzing venipuncture-obtained blood samples in laboratories. A non-invasive, cheap, point-of-care, and accurate hemoglobin test is needed everywhere. Our group has developed a non-invasive hemoglobin (Hgb) measurement system using 10-second Smartphone videos of the index fingertips. Custom hardware sets were used to illuminate the fingers. We tested four lighting conditions with wavelengths in the near-infrared spectrum suggested by the absorption properties of two primary components of blood-oxygenated hemoglobin and plasma. We found a strong linear correlation between our measured and laboratory-measured hemoglobin levels in 167 patients with a mean absolute percentage error (MAPE) of 5%. In our initial analysis, critical tasks were performed manually. Now, using the same data, we have automated or modified all the steps. For female subjects, we found a MAPE of 5.34% and MSE of 0.49. The new analyses, however, have suggested inexplicable inconsistencies in our results, which we attribute to laboratory measurement errors reflected in a non-normative distribution of hemoglobin levels in our studied patients, as well as excess noise in the specific signals we measured in the videos. Based on these encouraging results, and the promise of greater accuracy with our revised hardware and software tools, we now propose a rigorous validation study to demonstrate that this approach to hemoglobin measurement is appropriate for general clinical application.
- 24 March 2021
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Biomedical and Health Informatics
- Vol. 25 (5) , 1385-1396
Open AccessAutomated Cardiac Pulse Cycle Analysis From Photoplethysmogram (PPG) Signals Generated From Fingertip Videos Captured Using a Smartphone to Measure Blood Hemoglobin Levels
Two billion people are affected by hemoglobin (Hgb) related diseases. Usual clinical assessments of hemoglobin are conducted by analyzing venipuncture-obtained blood samples in laboratories. A non-invasive, cheap, point-of-care, and accurate hemoglobin test is needed everywhere. Our group has developed a non-invasive hemoglobin (Hgb) measurement system using 10-second Smartphone videos of the index fingertips. Custom hardware sets were used to illuminate the fingers. We tested four lighting conditions with wavelengths in the near-infrared spectrum suggested by the absorption properties of two primary components of blood-oxygenated hemoglobin and plasma. We found a strong linear correlation between our measured and laboratory-measured hemoglobin levels in 167 patients with a mean absolute percentage error (MAPE) of 5%. In our initial analysis, critical tasks were performed manually. Now, using the same data, we have automated or modified all the steps. For female subjects, we found a MAPE of 5.34% and MSE of 0.49. The new analyses, however, have suggested inexplicable inconsistencies in our results, which we attribute to laboratory measurement errors reflected in a non-normative distribution of hemoglobin levels in our studied patients, as well as excess noise in the specific signals we measured in the videos. Based on these encouraging results, and the promise of greater accuracy with our revised hardware and software tools, we now propose a rigorous validation study to demonstrate that this approach to hemoglobin measurement is appropriate for general clinical application.
- Open Access
- 30 December 2020
- Published by Nepal Journals Online (JOL) in Nepalese Medical Journal
- Vol. 3 (2) , 395-397
Doctor-Patient Communication for Adherence to Hypertension Treatment in Nepal
Effective doctor-patient communication is key to addressing the signifi cant issue of nonadherence to hypertension treatment in Nepal. Common clinical messages about hypertension are evaluated utilizing the framework of the Common-Sense Model of Self-Regulation for their role in shaping the patient models that underlie nonadherent behavior. Clinical communications and practices are recommended: to respectfully elicit and address patient reliance on self-identifi ed symptoms; to accompany warnings of hypertension’s serious consequences with specifi c individual action-plans for durable effects; to emphasize the necessity of long-term continuous treatment without creating fears of dependence and withdrawal effects or burdensome monitoring and counseling; to inform of side-effects while presenting medication as nontoxic and necessary for the body’s maintenance of a healthy balance. By acknowledging the patient as an active agent engaged in self-regulation and by employing culturally consonant concepts (often Ayurvedic), we can encourage accurate patientillness and treatment representations that guide medication adherence.
- 30 December 2020
- Published by Nepal Journals Online (JOL) in Nepalese Medical Journal
- Vol. 3 (2) , 395-397
Open AccessDoctor-Patient Communication for Adherence to Hypertension Treatment in Nepal
Effective doctor-patient communication is key to addressing the signifi cant issue of nonadherence to hypertension treatment in Nepal. Common clinical messages about hypertension are evaluated utilizing the framework of the Common-Sense Model of Self-Regulation for their role in shaping the patient models that underlie nonadherent behavior. Clinical communications and practices are recommended: to respectfully elicit and address patient reliance on self-identifi ed symptoms; to accompany warnings of hypertension’s serious consequences with specifi c individual action-plans for durable effects; to emphasize the necessity of long-term continuous treatment without creating fears of dependence and withdrawal effects or burdensome monitoring and counseling; to inform of side-effects while presenting medication as nontoxic and necessary for the body’s maintenance of a healthy balance. By acknowledging the patient as an active agent engaged in self-regulation and by employing culturally consonant concepts (often Ayurvedic), we can encourage accurate patientillness and treatment representations that guide medication adherence.
- Open Access
- 1 October 2020
- Published by Scientific Scholar in Indian Journal of Palliative Care
- Vol. 26 (4) , 476-478
Symptoms in Nepali Patients with Incurable Cancers: Implications for Interventions
Aim: The poor quality and limited extent of palliative care services are of concern across the globe. To identify and measure patients' symptoms in Nepal, using a cell phone questionnaire platform, the investigators conducted and previously reported a cross-sectional study of Nepali adults. The unreported details of pain and other symptoms in these study data are here considered together with possible explanations and implications for interventions to lessen these symptoms. Methods: In a "snapshot" cross-sectional study of patients under regular care in three tertiary care Nepalese centers, we questioned 383 patients with incurable cancers using a 15-item cell phone-validated instrument to describe their major current symptoms and their intensities. The distributions of 11 symptom-level scores and the correlations between pain and different symptom scores were determined. Results: Thirty-eight percent of the population (142/383) had maximal pain scores which were in the severe range, and 25% (97/383) had such scores where they were evaluated. Patients reported moderate-to-severe tiredness 48% (183/383), depression 45% (172/383), anxiety 56% (217/383), poor appetite 64% (246/383), sleep quantity 64% (246/383), and sleep quality 64% (247/383). Conclusions: The significant fractions of patients with severe maximal and at-evaluation pain scores suggest that inadequate recognition and treatment of such symptoms characterized care of these regularly seen patients. The high fractions of patients with mood and sleep disturbances support this reading, suggesting helplessness and hopelessness, all addressable with psychosocial, environmental, and nontoxic, inexpensive pharmacological interventions.
- 1 October 2020
- Published by Scientific Scholar in Indian Journal of Palliative Care
- Vol. 26 (4) , 476-478
Open AccessSymptoms in Nepali Patients with Incurable Cancers: Implications for Interventions
Aim: The poor quality and limited extent of palliative care services are of concern across the globe. To identify and measure patients' symptoms in Nepal, using a cell phone questionnaire platform, the investigators conducted and previously reported a cross-sectional study of Nepali adults. The unreported details of pain and other symptoms in these study data are here considered together with possible explanations and implications for interventions to lessen these symptoms. Methods: In a "snapshot" cross-sectional study of patients under regular care in three tertiary care Nepalese centers, we questioned 383 patients with incurable cancers using a 15-item cell phone-validated instrument to describe their major current symptoms and their intensities. The distributions of 11 symptom-level scores and the correlations between pain and different symptom scores were determined. Results: Thirty-eight percent of the population (142/383) had maximal pain scores which were in the severe range, and 25% (97/383) had such scores where they were evaluated. Patients reported moderate-to-severe tiredness 48% (183/383), depression 45% (172/383), anxiety 56% (217/383), poor appetite 64% (246/383), sleep quantity 64% (246/383), and sleep quality 64% (247/383). Conclusions: The significant fractions of patients with severe maximal and at-evaluation pain scores suggest that inadequate recognition and treatment of such symptoms characterized care of these regularly seen patients. The high fractions of patients with mood and sleep disturbances support this reading, suggesting helplessness and hopelessness, all addressable with psychosocial, environmental, and nontoxic, inexpensive pharmacological interventions.
- 14 September 2020
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 184 (3) , 675-682
Clinical practice to address tamoxifen nonadherence
The primary and secondary benefits of tamoxifen as adjuvant therapy in women with hormone-receptor-positive breast cancer are substantial: a 1% decrease in the risk of death each year for 10 years with each additional year of treatment during the first 5 years. Considerable data, however, indicate that these benefits are lost to many patients because of treatment nonadherence. Nonadherence is examined within the framework of the Common-Sense Model of Self-Regulation to describe patients’ models of disease and treatment that organize their thinking and behavior, and the crucial role of the practitioner in addressing and altering these models. Common patient education and social communications about patients’ hormone-receptor-positive breast cancer and tamoxifen treatment promote an acute disease paradigm in which cancer occurs within specific locations and is either present or absent. We recommend that clinicians communicate the concepts of hormone-receptor-positive breast cancer as follows: i. a non-dichotomous systemic disorder entailing a treatment goal of homeostasis and disease quiescence and ii. a disorder undetectable by currently available tests in subclinical states. Equally important, the clinician can provide a comprehensive picture of the well-documented secondary effects of tamoxifen, noting in particular the beneficial effects. Specific action plans, grounded in individual patient understanding, can be developed and reinforced, in an ongoing process that validates and integrates patient values and goals as they change over time.
- 14 September 2020
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 184 (3) , 675-682
Clinical practice to address tamoxifen nonadherence
The primary and secondary benefits of tamoxifen as adjuvant therapy in women with hormone-receptor-positive breast cancer are substantial: a 1% decrease in the risk of death each year for 10 years with each additional year of treatment during the first 5 years. Considerable data, however, indicate that these benefits are lost to many patients because of treatment nonadherence. Nonadherence is examined within the framework of the Common-Sense Model of Self-Regulation to describe patients’ models of disease and treatment that organize their thinking and behavior, and the crucial role of the practitioner in addressing and altering these models. Common patient education and social communications about patients’ hormone-receptor-positive breast cancer and tamoxifen treatment promote an acute disease paradigm in which cancer occurs within specific locations and is either present or absent. We recommend that clinicians communicate the concepts of hormone-receptor-positive breast cancer as follows: i. a non-dichotomous systemic disorder entailing a treatment goal of homeostasis and disease quiescence and ii. a disorder undetectable by currently available tests in subclinical states. Equally important, the clinician can provide a comprehensive picture of the well-documented secondary effects of tamoxifen, noting in particular the beneficial effects. Specific action plans, grounded in individual patient understanding, can be developed and reinforced, in an ongoing process that validates and integrates patient values and goals as they change over time.
- Open Access
- 1 December 2019
- Published by American Society of Clinical Oncology (ASCO) in Journal of Global Oncology
- Vol. 5 (5) , 1-3
Improving Cancer Outcomes In Low- and Middle-Income Countries
- 1 December 2019
- Published by American Society of Clinical Oncology (ASCO) in Journal of Global Oncology
- Vol. 5 (5) , 1-3
Open AccessImproving Cancer Outcomes In Low- and Middle-Income Countries